Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/26/2012 | US20120100573 Cytomegalovirus intron a fragments |
04/26/2012 | US20120100570 Site-Specific Incorporation of Redox Active Amino Acids into Proteins |
04/26/2012 | US20120100556 Functional Expression of Higher Plant Nitrate Transporters in Pichia Pastoris |
04/26/2012 | US20120100253 Maltotriosyl transferase, process for production thereof, and use thereof |
04/26/2012 | US20120100249 Novel asparaginase enzyme |
04/26/2012 | US20120100205 Components for producing amphoteric liposomes |
04/26/2012 | US20120100180 Methods for proliferation of antigen-specific t cells |
04/26/2012 | US20120100177 Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
04/26/2012 | US20120100172 Immunogenic streptococcus pneumoniae peptides and peptide-multimers |
04/26/2012 | US20120100169 Vaccine for Cervical Cancer |
04/26/2012 | US20120100168 Cyclovirus and methods of use |
04/26/2012 | US20120100166 Ang-2 Binding Complexes and Uses Thereof |
04/26/2012 | US20120100159 Anti-tat226 antibodies and immunoconjugates |
04/26/2012 | US20120100155 Pharmaceutical agent |
04/26/2012 | US20120100153 Stable and soluble antibodies |
04/26/2012 | US20120100152 Anti-human cd52 immunoglobulins |
04/26/2012 | US20120100148 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
04/26/2012 | US20120100143 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon |
04/26/2012 | US20120100140 Stabilized fc polypeptides with reduced effector function and methods of use |
04/26/2012 | US20120100139 CD86 Antagonist Multi-Target Binding Proteins |
04/26/2012 | US20120100116 Neuron generation, regeneration and protection |
04/26/2012 | US20120100099 Fusion proteins having mutated immunoglobulin hinge region |
04/26/2012 | US20120100076 Methods of modulating cold sensory perception |
04/26/2012 | US20120100074 Humanized antibodies against light and uses thereof |
04/26/2012 | DE102010042910A1 Temperaturstabile ß-Pyranosidase Temperature stable ß-Pyranosidase |
04/26/2012 | DE10009143B4 Nachweis von Humanen Papillomviren Detection of human papillomavirus |
04/26/2012 | CA2852904A1 Assays, methods and kits for predicting renal disease and personalized treatment strategies |
04/26/2012 | CA2820536A1 Control of pathogens and parasites |
04/26/2012 | CA2820421A1 Kit for detecting bovine leukemia virus(blv), and use thereof |
04/26/2012 | CA2818662A1 Nucleic acid molecule inducing rna interference, and uses thereof |
04/26/2012 | CA2815264A1 1-deoxy-d-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis |
04/26/2012 | CA2815219A1 Apparatus, methods, and compositions for endodontic treatments |
04/26/2012 | CA2815212A1 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
04/26/2012 | CA2815102A1 Wdhd1 peptides and vaccines including the same |
04/26/2012 | CA2815100A1 C18orf54 peptides and vaccines including the same |
04/26/2012 | CA2815083A1 Method for increasing plant oil production |
04/26/2012 | CA2815080A1 Anti-folate receptor alpha antibody glycoforms |
04/26/2012 | CA2815076A1 Varietal counting of nucleic acids for obtaining genomic copy number information |
04/26/2012 | CA2815070A1 Thermostable trichoderma cellulase |
04/26/2012 | CA2815046A1 Human antibodies and specific binding sequences thereof for use in neurological disease |
04/26/2012 | CA2815000A1 Discovery of regulatory t cells programmed to suppress an immune response |
04/26/2012 | CA2814947A1 Fusion protein with factor ix activity |
04/26/2012 | CA2814892A1 Novel fatty acid desaturases, elongases, elongation components and uses thereof |
04/26/2012 | CA2814860A1 Methods of modifying transcriptional regulatory networks in stem cells |
04/26/2012 | CA2814513A1 Potyvirus resistance in potato |
04/26/2012 | CA2814373A1 Identification of antibodies specific for lyssaviruses and methods of their use |
04/26/2012 | CA2813431A1 Production of butanol from carbon monoxide by a recombinant microorganism |
04/26/2012 | CA2756346A1 Modular method for rapid assembly of dna |
04/25/2012 | EP2444506A1 Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
04/25/2012 | EP2444498A1 Gene therapy for treatment of cancer and hyperproliferative diseases |
04/25/2012 | EP2444497A1 Gene silencing |
04/25/2012 | EP2444496A1 Plant promoters, terminators, genes, vectors and related transformed plants |
04/25/2012 | EP2444495A1 Secretion of recombinant polypeptides in the extracellular medium of diatoms |
04/25/2012 | EP2444494A1 RNA antagonist compounds for the modulation of PCSK9 |
04/25/2012 | EP2444493A1 Protein having novel prenylation enzyme activity and gene encoding same |
04/25/2012 | EP2444492A1 Chicken-derived anti-lox-1 antibody |
04/25/2012 | EP2444484A1 Method for producing antibodies using cancer cells |
04/25/2012 | EP2444482A1 Modulation of SGLT2 expression |
04/25/2012 | EP2444416A1 1-deoxy-D-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis |
04/25/2012 | EP2444415A1 1-Deoxy-D-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis |
04/25/2012 | EP2444409A2 Compositions and methods for the treatment of immune related diseases |
04/25/2012 | EP2444099A1 Antibodies and related molecules that bind to 161P2F10B proteins |
04/25/2012 | EP2443254A2 Improved methods for forensic dna quantitation |
04/25/2012 | EP2443251A1 Improvement of low-biomass soil dna/rna extraction yield and quality |
04/25/2012 | EP2443242A2 Producer cells for replication competent retroviral vectors |
04/25/2012 | EP2443241A1 Production of viral capsids |
04/25/2012 | EP2443240A2 Plants having enhanced yield-related traits and a method for making the same |
04/25/2012 | EP2443239A2 Novel stringent selectable markers |
04/25/2012 | EP2443238A2 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
04/25/2012 | EP2443237A2 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene |
04/25/2012 | EP2443236A2 Methods and compositions for long fragment read sequencing |
04/25/2012 | EP2443234A1 Nicotiana benthamiana plants deficient in xylosyltransferase activity |
04/25/2012 | EP2443231A2 Generation of induced pluripotent stem cells from cord blood |
04/25/2012 | EP2443150A2 Anti-vegf antibodies and their uses |
04/25/2012 | EP2442816A1 Compositions and methods for modulation of smn2 splicing in a subject |
04/25/2012 | EP2442792A2 Lipid formulated dsrna targeting the pcsk9 gene |
04/25/2012 | EP2442666A1 High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica |
04/25/2012 | EP2257624B1 Methods and compositions |
04/25/2012 | EP2220233B1 Dicarboxylic acid production in eukaryotes |
04/25/2012 | EP2151496B1 Method for evaluation of drug sensitivity by analysis of pomc gene |
04/25/2012 | EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions |
04/25/2012 | EP2102239B1 Improved immunoglobulin libraries |
04/25/2012 | EP2068909B1 Modified fgf-21 polypeptides and their uses |
04/25/2012 | EP2003199B1 Glucose dehydrogenase |
04/25/2012 | EP1966238B1 Interleukin-12p40 variants with improved stability |
04/25/2012 | EP1951887B1 Staphylococcus aureus strain cyl1892 |
04/25/2012 | EP1891232B1 Pcr diagnostics of dermatophytes and other pathogenic fungi |
04/25/2012 | EP1807518B1 Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
04/25/2012 | EP1791962B1 Promoter molecules isolated from brassica napus for use in plants |
04/25/2012 | EP1789447B1 Method of delivering rna interference and uses thereof |
04/25/2012 | EP1716173B1 Carcinoembryonic antigen fusion protein and uses thereof |
04/25/2012 | EP1689766B1 Expression in filamentous fungi of protease inhibitors and variants thereof |
04/25/2012 | EP1682581B1 Igg fc fragment for a drug carrier and method for the preparation thereof |
04/25/2012 | EP1661905B1 Novel artificial nucleic acids of n-o bond crosslinkage type |
04/25/2012 | EP1636371B1 Negative strand rna virus replicon |
04/25/2012 | EP1601767B1 USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA |
04/25/2012 | EP1458855B1 Method for the generation of proliferating and differentiating cell lines |
04/25/2012 | EP1391502B1 Host microorganisms |
04/25/2012 | EP1379551B1 Adp-ribosylating bacterial toxins |
04/25/2012 | EP1356277B1 Method for altering cell fate |